Source: Health Products Regulatory Authority (IE) Revision Year: 2014 Publisher: Servier Laboratories (Ireland) Limited Block 2 West Pier Business Campus Old Dunleary Road Dun Laoghaire Co. Dublin.
VASTAREL 20 mg Film-coated Tablets.
| Pharmaceutical Form |
|---|
|
|
Each tablet contains 20mg trimetazidine dihydrochloride.
Excipients:
Ponceau 4R (E124): 0.369 mg per tablet.
Sunset yellow (E110): 0.042 mg per tablet.
For full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Trimetazidine |
In patients with ischaemic heart disease, trimetazidine acts as a metabolic agent, preserving the myocardial high-energy phosphate intracellular levels. |
| List of Excipients |
|---|
|
Maize starch |
Cartons of 30, 60 and 90 tablets in PVC/Aluminium blisters.
Not all pack sizes may be marketed.
Servier Laboratories (Ireland) Limited
Block 2
West Pier Business Campus
Old Dunleary Road
Dun Laoghaire
Co. Dublin.
PA 68/10/1
Date of first authorisation: 8th April 1987
Date of last renewal: 8th April 2007
| Drug | Countries | |
|---|---|---|
| VASTAREL | Austria, Brazil, Cyprus, Ecuador, France, Hong Kong, Ireland, Japan, Malta, Singapore, Tunisia, Turkey |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
